Indirect Treatment Comparisons Of Obinutuzumab (Ga101) Plus Chlorambucil (Clb) Versus Bendamustine And Versus Ofatumumab Plus Clb In Patients With Chronic Lymphocytic Leukemia
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1314
https://www.valueinhealthjournal.com/article/S1098-3015(14)01365-5/fulltext
Title :
Indirect Treatment Comparisons Of Obinutuzumab (Ga101) Plus Chlorambucil (Clb) Versus Bendamustine And Versus Ofatumumab Plus Clb In Patients With Chronic Lymphocytic Leukemia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01365-5&doi=10.1016/j.jval.2014.03.1314
First page :
A225
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
783